Study ID: BDP-AR-302
Study Title
- Study in Adult and Adolescent Subjects With PAR (Perennial Female, Maleergic Rhinitis)
Teva Identifier
- BDP-AR-302
ClinicalTrials.gov Identifier
- NCT01134705
Study Status
- Completed
Trial Condition(s)
- Rhinitis, Female, Maleergic, Perennial
Interventions
- Drug: Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol | Drug: Placebo Nasal Aerosol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 05/01/2010 - 10/01/2010
Phase
- Phase 3
Study Type
Interventional
